Press Releases
A pooled CRISPR library screen is only as reliable as the representation that survives each experimental bottleneck. Library size, starting cell number, multiplicity of infection, selection pressure, replicate design and sequencing depth are connected variables. Optimizing one while ignoring the others can create false negatives, unstable guide representation or a hit list that is difficult to reproduce.
Define the phenotype before choosing the library. A drug-resistance screen, viability screen and pathway-specific screen can require different perturbation systems, selection windows and readouts.
Genome-wide libraries maximize discovery breadth but require more cells and sequencing. Targeted libraries can be more efficient when the project already focuses on a pathway, gene family or curated target set.
OBiO’s CRISPR library screening services support genome-wide and custom libraries across knockout, CRISPRi and CRISPRa formats.
Coverage describes how many cells represent each guide. The correct number depends on the screen design, but the principle is consistent: every major bottleneck should retain enough cells so random loss does not dominate guide abundance.
Many pooled screens use a relatively low MOI so a transduced cell is likely to receive a limited number of guides. The exact MOI should be validated in the target model because susceptibility to lentiviral transduction varies widely across cell types.
When the screen requires custom vector production, the delivery step can be coordinated through lentiviral library packaging so titer, cell number and planned MOI are reviewed together.
Include non-targeting controls, positive controls and biological replicates. Baseline samples collected before the main selection step help distinguish selection-driven changes from variation that already existed after transduction.
The selection should be strong enough to create measurable separation but not so extreme that most of the library disappears before meaningful biology can be observed. Pilot experiments can help set dose, duration or sorting thresholds.
After selection, integrated guide sequences are recovered from genomic DNA and prepared for NGS. DNA input and sequencing depth should be sufficient to preserve the information carried by the surviving library representation.
The analysis compares guide abundance between conditions and identifies targets that become enriched or depleted. Gene-level interpretation should consider the consistency of multiple guides rather than relying on a single extreme sequence.
Primary-screen hits should be retested with independent guides and, when possible, an orthogonal assay. This step separates robust biological drivers from guide-specific effects and statistical noise.
If custom vectors are required before the screen, OBiO can also coordinate plasmid construction with library packaging and screening.
There is no universal value for every cell type. Many pooled screens use a low MOI to limit the number of guide integrations per cell, but the correct setting should be experimentally validated in the target model.
Insufficient coverage increases the chance that guides disappear because of random sampling rather than because of the biological selection, reducing sensitivity and reproducibility.
Yes. Replicates are important for distinguishing reproducible biological signals from technical variation.
Yes. OBiO’s workflow can include library packaging, screening, sequencing and bioinformatics. Request a screening workflow review.
Request Now